LSMNF yields 2.39% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, LSMNF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LSMNF + JNJ for your $10,000?
lastminute.com N.V. operates in the online travel industry in Italy, Spain, the United Kingdom, France, Germany, and internationally. It operates through Online Travel Agency (OTA), Meta-search, Media, and Other segments. The company provides mobile apps and websites in approximately 17 languages and 40 countries, which enable travelers to search, compare, and book flights, vacation packages and cruises, hotel accommodations, car rentals, and other travel products and services. It also directs traffic from its websites to the sites of the OTAs, airlines, and other direct providers. In addition, the company operates as a seller of web-based advertising spaces and media contents primarily on OTA platforms, web sites, and third-party partners available spaces. Its primary brands include lastminute.com, weg.de, Jetcost, Volagratis, Rumbo, Bravofly, Hotelscan, Crocierissime, and Forward, as well as Madfish, HolidayiQ, Wayn, and Pigi Shipping. The company was formerly known as Bravofly Rumbo Group N.V. and changed its name to lastminute.com N.V. in May 2015. lastminute.com N.V. was founded in 2004 and is based in Amsterdam, the Netherlands.
Full LSMNF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.